SureChill

ElectriFI provided equity in the amount of USD 1 million to SureChill to scale its efforts in delivering cutting-edge cooling solutions critical for global health and sustainability.

Project overview

SureChill provides sustainable, affordable and patented cooling solutions to medical facilities, and more recently to homes and small businesses (HSB) in off/weak grid areas.

Sure Chill is a key player in the UNICEF-controlled WHO vaccine cold chain, and has reached over 70 countries, deployed 22,000 vaccine refrigerators, and facilitated 90M safe vaccinations. Since few years the company also targets SSA mass market refrigeration, with hubs in Kenya and Nigeria, servicing these markets and many more SSA countries through a multitude of different sales channels and models (inc B2B, retail, Cooling as a Service, …).

Funding objective

ElectriFI will participate in the second closing of the Series B round, alongside other investors, to support the roll-out of the business models in Kenya and Nigeria (with ElectriFI funding earmarked to Kenya).

Read more:

• SureChill secures strategic investment to expand its footprint in providing sustainable and innovative cold chain solutions in emerging markets
• Final disclosure
• SureChill

Investment rationale

ElectriFI supports this investment for the following reasons: i) Mature, proven, certified and patented technology enabling cooling for long periods, with no or limited grid connection, and no batteries, resulting in a solution for the end customer at relatively affordable CAPEX and low/no OPEX, ii) Business model provides an interesting combination of large tender medical segment, combined with a very diversified multi-channel sales approach in the HSB segment, allowing for lean sales and operations and maximized reach and impact.